ImmunoGen
Why Robinhood?
You can watch ImmunoGen and buy or sell other stocks, ETFs, and their options commission-free!About IMGN
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151.
IMGN Key Statistics
Stock Snapshot
With a market cap of 8.72B, ImmunoGen(IMGN) trades at $31.23. The stock has a price-to-earnings ratio of -104.24.
On 2026-03-02, ImmunoGen(IMGN) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for ImmunoGen(IMGN) stock has reached 0, versus its average volume of 10.88M.
Over the past 52 weeks, ImmunoGen(IMGN) stock has traded between a high of $31.25 and a low of $3.61.
Over the past 52 weeks, ImmunoGen(IMGN) stock has traded between a high of $31.25 and a low of $3.61.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.